88 related articles for article (PubMed ID: 1539357)
1. Does immunosuppressive therapy influence the recovery of bone disease in kidney transplant recipients?
Gonzalez MT; Gonzalez C; Bover J; Bonnin R; Mariñoso ML; Serrano S; Castelao AM; Griño JM; Alsina J
Transplant Proc; 1992 Feb; 24(1):99-102. PubMed ID: 1539357
[No Abstract] [Full Text] [Related]
2. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
Cherqui D; Duvoux C; Salvat A; Lauzet JY; Metreau JM; Julien M; Fagniez PL; Dhumeaux D
Transplant Proc; 1995 Feb; 27(1):1134-5. PubMed ID: 7878824
[No Abstract] [Full Text] [Related]
3. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
4. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study.
Opelz G
Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292
[TBL] [Abstract][Full Text] [Related]
5. A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.
Niese D
Transplant Proc; 1995 Apr; 27(2):1849-56. PubMed ID: 7725531
[No Abstract] [Full Text] [Related]
6. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
8. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF
Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
[No Abstract] [Full Text] [Related]
9. Monitoring of donor sensitization in kidney transplant recipients by flow cytometric crossmatch.
Cinti P; Bachetoni A; Baiano V; Pretagostini R; Poli L; Berloco P; Renna Molajoni E; Cortesini R
Transplant Proc; 1993 Dec; 25(6):3265-6. PubMed ID: 8266536
[No Abstract] [Full Text] [Related]
10. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
11. Cadaveric renal transplantation with cyclosporine monotherapy.
Aikawa A; Sells RA; Bakran A; Tewari A
Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
[No Abstract] [Full Text] [Related]
12. Is HLA matching worthwhile in pancreatic transplantation?
Hopt UT; Büsing M; Schareck W; Pfeffer F; Irkin I; Becker HD
Transplant Proc; 1992 Jun; 24(3):909-10. PubMed ID: 1604664
[No Abstract] [Full Text] [Related]
13. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study.
Masri MA; Shakuntala V; Dhawan IK; Zahir M; Shanwaz M; Hayes K; Pingle A
Transplant Proc; 1993 Jun; 25(3):2248-9. PubMed ID: 8516889
[No Abstract] [Full Text] [Related]
14. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
15. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
Reissi D; Bardideh A; Samadzadeh B; Razi A
Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
[No Abstract] [Full Text] [Related]
16. Do steroids matter in one-haplotype pediatric renal allograft recipients on cyclosporine/azathioprine?
David-Neto E; Ianhez LE; Nahas WC; Krasilcic S; Sabbaga E; Arap S
Transplant Proc; 1994 Feb; 26(1):95-6. PubMed ID: 8109040
[No Abstract] [Full Text] [Related]
17. Aggressive early cyclosporine therapy is desirable in pediatric renal transplantation.
al-Uzri A; Conley SB; Orlandi P; So S; Salvatierra O
Transplant Proc; 1994 Feb; 26(1):88-90. PubMed ID: 8109036
[No Abstract] [Full Text] [Related]
18. Superior long-term kidney graft survival in patients on maintenance immunosuppression with cyclosporine and azathioprine.
Opelz G
Transplant Proc; 1993 Feb; 25(1 Pt 2):1289-90. PubMed ID: 8442115
[No Abstract] [Full Text] [Related]
19. Steroid withdrawal in kidney transplant recipients: is it a safe option?
Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
[No Abstract] [Full Text] [Related]
[Next] [New Search]